BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Vitamin D Supplementation in IBS

Not Applicable

Terminated

Conditions: Vitamin D Deficiency
Irritable Bowel Syndrome
Abdominal Pain

Interventions: Dietary Supplement: Vitamin D
Dietary Supplement: placebo

First Posted Date: 2017-05-10

Last Posted Date: 2020-05-06

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 7

Registration Number: NCT03148288

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Surgical vs. Lifestyle in Obese Older Adults

Not Applicable

Terminated

Conditions: Obesity

Interventions: Behavioral: Exercise program
Procedure: WLS
Dietary Supplement: Nutrition

First Posted Date: 2017-05-02

Last Posted Date: 2019-07-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 2

Registration Number: NCT03137329

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings

Completed

Conditions: Seizures
Epilepsy

First Posted Date: 2017-04-06

Last Posted Date: 2017-04-06

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 40

Registration Number: NCT03103425

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Ischemic Conditioning in STEMI Patients

Not Applicable

Completed

Conditions: Cardiac Arrest

Interventions: Procedure: Remote post-ischemic conditioning

First Posted Date: 2017-03-31

Last Posted Date: 2024-10-29

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 29

Registration Number: NCT03097419

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Migraine and Homeostasis:What Can we Learn From Glucose

Not Applicable

Suspended

Conditions: Migraine Headache

Interventions: Other: Luna Bar

First Posted Date: 2017-03-31

Last Posted Date: 2023-08-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 30

Registration Number: NCT03097536

Locations: 🇺🇸
Beth Israel Deaconess Medial Center, Boston, Massachusetts, United States

Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias

Completed

Conditions: Electroanatomic Mapping
Cardiac Arrhythmias
Cardiac Ablation

Interventions: Device: Rhythmia Mapping System

First Posted Date: 2017-03-29

Last Posted Date: 2017-03-29

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT03094221

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Brief Behavioral Treatment for Sleep Problems in IBS Study

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome
Sleep Disturbance

Interventions: Behavioral: Brief Behavioral Treatment for Sleep

First Posted Date: 2017-03-23

Last Posted Date: 2020-03-04

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 25

Registration Number: NCT03087799

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

Not Applicable

Active, not recruiting

Conditions: Distal Radius Fracture
Hip Fractures
Osteoporosis

Interventions: Device: Reference Point Indentation

First Posted Date: 2017-03-09

Last Posted Date: 2024-08-28

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 190

Registration Number: NCT03076034

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist

Phase 1

Terminated

Conditions: Postural Orthostatic Tachycardia Syndrome
Orthostatic Intolerance

Interventions: Drug: Droxidopa
Drug: Atenolol
Drug: Placebos

First Posted Date: 2017-03-06

Last Posted Date: 2017-05-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 8

Registration Number: NCT03070730

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Center for Autonomic and Peripheral Nerve Disorders - Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Phase 2

Recruiting

Conditions: Acute Myelogenous Leukemia

Interventions: Biological: DC/AML Fusion Vaccine
Other: Observation

First Posted Date: 2017-02-23

Last Posted Date: 2023-06-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 75

Registration Number: NCT03059485

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

and more 1 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy